{ "items": [ "\n\n
\n \n Conference paper\n \n
\n \n\n \n \n \nSingh N. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S406 - S406
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nVai B. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S444 - S444
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSchmaal L. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S394 - S395
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCapit\u00e3o LP. et al, (2015), Psychol Med, 45, 2295 - 2308
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTerbeck S. et al, (2015), Psychopharmacology (Berl), 232, 2951 - 2958
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPflanz CP. et al, (2015), Psychopharmacology (Berl), 232, 2139 - 2147
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPflanz CP. et al, (2015), Psychopharmacology, 232, 2139 - 2147
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCowen PJ. and Browning M., (2015), World Psychiatry, 14, 158 - 160
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCowen PJ., (2015), BMJ, 350
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCleare A. et al, (2015), J Psychopharmacol, 29, 459 - 525
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSchmidt K. et al, (2015), Psychopharmacology (Berl), 232, 1793 - 1801
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSchmidt K. et al, (2015), Psychopharmacology, 232, 1793 - 1801
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCooper CM. et al, (2015), J Psychopharmacol, 29, 582 - 590
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMcCrea RL. et al, (2015), PLoS ONE, 10
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nHarmer C. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S57 - S58
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nCooper CM. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S68 - S69
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nFreeman D. et al, (2015), Schizophr Bull, 41, 391 - 399
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nGodlewska BR. et al, (2015), Psychopharmacology (Berl), 232, 501 - 507
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMannie ZN. et al, (2015), Psychol Med, 45, 375 - 380
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLevy N. et al, (2015), Philosophy, Psychiatry and Psychology, 21, 135 - 137
\n \n \n \n\n
\n \n \n \n